Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  • Where available, URLs for the references have been provided.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

 

Scope of the journal

The Journal of Enam Medical College is a peer-reviewed journal and is published thrice a year. It publishes original papers, reviews concerned with recent practices, case reports of exceptional merits and images in clinical medicine. Authors are invited to submit articles in all the fields of medicine, with a wide spectrum of coverage including clinical medicine, basic sciences, epidemiology, diagnostics, therapeutics, public health and standards of health care in relation to the concerned speciality. Review articles of current interest and a high standard of scientific value are considered for publication.

Submission of manuscripts

Two typed copies (hard copies) of the article and one soft copy on a CD-ROM processed in MS Word (*.doc format only) should be submitted to the Editor-in-Chief. Alternatively, manuscripts may also be submitted electronically through Email: thejemc2011@yahoo.com. Manuscripts must be accompanied by a covering letter signed by all authors stating that the data have not been published elsewhere in whole or in part and all authors agree publication of their article in Journal of Enam Medical College. If the work has been conducted abroad, the article must be accompanied by a certificate from the head of the institute where the work has been done. Authors need not to pay for publication. 

Editorial process

All submitted manuscripts are primarily reviewed by the editors of the journal and then undergo through a double-blind peer review process and finally editors make their decisions about publishing papers in the journal. Manuscripts of rejected articles are not returned, but the principal author or the author for correspondence is informed of rejection of the article. Ethical aspects are considered in the assessment of the paper. The decision on the priority of publication is strictly determined by the editorial board. 

The editorial board reserves the right to edit and if necessary, shorten any material accepted for publication and to crop/trim any illustration to conform to the style of the text. The editorial board does not subscribe to the views expressed in the article written by the author or authors and published in this journal.

Ethics

Procedure of studies on humans should be in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975 (revised in 2000, available at http://www.wma.net/e/policy/17-ce.html). The ethical standards of experiments must be in accordance with the guidelines provided by the COMMITTEE FOR THE PURPOSE OF CONTROL AND SUPERVISION ON EXPERIMENTS ON ANIMALS (CPCSEA) for animals and ICMR for humans. 

A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section. Evidence for approval by a local Ethics Committee must be supplied by the authors on demand. 

Authors should obtain permission for all fully borrowed, adapted and modified tables, illustration or photograph and provide a credit line in the footnote.  

Manuscript preparation

The journal considers manuscripts prepared in accordance with the guidelines laid down by the International Committee of Medical Journal Editors (www.icmje.org/index.html).

The text should be typewritten in 12-point in Times New Roman font, double spaced on one side of the paper and not larger than ISO A4 (210 × 297 mm) with a 3 cm margin and pages should be numbered consecutively. 

Abbreviations and symbols must be standard and SI units should be used throughout. Whenever possible, drugs should be given their approved generic names. Acronyms should be used sparingly. 

The level of English should meet the journal's standard. Please check for grammatical and spelling errors, and poorly constructed sentences, and refine the language carefully. Authors not fluent in English are advised to have their manuscript checked by a colleague with a good command of the language. 

Manuscript should contain

  1. Title page
  2. Abstract (structured)
  3. Introduction
  4. Materials and Methods
  5. Results (with tables and figures, where required)
  6. Discussion
  7. Acknowledgement (if any)
  8. References

Title page

The title page should bear the names of the author(s) and the name and address of the institution or laboratory where the work has been carried out, in addition to the title of the paper. The full address of the principal author or the author to whom proofs will be sent should be given including e-mail account number. A short (running) title of not more than 45 characters should be given. 

Abstract

The abstract should not exceed 250 words and should state concisely what was done, the main findings and how the work was interpreted. The abstract should be structured having background, objectives, materials and methods, results and conclusion. Abstracts of case reports and review articles may not be structured. Below the abstract, three to five appropriate key words relevant to the article should be mentioned. 

Introduction

Introduction should contain brief review of the subject, state the purpose of the article and summarise the rationale for the study or observation and should contain strictly pertinent references. 

Materials and Methods

  1. Selection criteria of the subjects (patients or laboratory animals, controls) should be described clearly, including eligibility and exclusion criteria and a brief description of the source population.
  2. Regarding technical information, methods, apparatus (manufacturer’s name and address in parentheses), and procedures are to be described. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations.
  3. All drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration are to be described.
  4. Reports of randomised clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomisation, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement (available at http://www.consort-statement.org).
  5. Statistical methods to analyse and summarise data must be specified. Specify the computer software used.

Results

Results should be presented in the text in logical sequence with tables and illustrations (where necessary) and should be described without any comment. All the data in the tables or illustrations should not be repeated in the text; only important observations should be emphasised or summarised. Do not duplicate data in tables and figures. Tables and figures should be inserted in the text where those are referred to.

Tables should be self-explanatory, as few as possible and should present only essential data. Explanatory matters should be placed in footnotes. Explain in footnotes all non-standard abbreviations used in the table. For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||, **, ††, ‡‡. Each table should have a title or caption with Roman numbers. Do not use internal horizontal or vertical lines.

All photographs, graphs, diagrams should be referred to as figures and should be numbered consecutively in the text in Arabic numerals. All illustrations must be in JPEG format at a resolution of 300 dots/inch (DPI) or higher. Photomicrographs should have internal scale markers and should include in the legend the original magnification and the stain used. Subject/patient must not be identifiable on the photograph. If this is unavoidable, written consent from the subject or legal guardian must be obtained.

Discussion

This section should present comprehensive analysis of the results in the light of any previous research. Emphasise the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other materials given in the Introduction or the Results section. Include the implications of the findings and their limitations, including implications for future research. Relate the observations to other relevant studies. State new hypotheses when warranted, but clearly label them as such.

Acknowledgement

Contributions by any person or department or institution, but not justifying authorship, may be acknowledged. Nature of support, such as general support by a departmental chair, technical help, financial and material support, should be specified. 

References

References should follow the Vancouver format. In the text, references should appear as numbers starting at 1. At the end of the paper these should be listed (double spaced) in numerical order according to the order of citation in the text. All authors should be quoted for papers with up to 6 authors, for papers with more than 6 authors the first 6 only should be quoted followed by et al. Abbreviations for title of medical periodical should conform to those used in the latest edition of Index Medicus (www.ncbi.nlm.nih.gov/journals?itool=sidebar). The first and last page numbers for each reference should be provided. Abstracts and letters must be identified as such. Authors must check references against original sources for accuracy. Examples of references are given below.

Articles in journals

  1. Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ. Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: results from the VOYAGER meta-analysis. Eur J Prev Cardiol 2016; 23: 744−747.
  2. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018; 15(1): 11–20.
  3. Oh H, Jun DW, Saeed WK,Nquyen MH. Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment. Clin Mol Hepatol 2016; 22(3): 327–335.

Chapter in a book

  1. Kumar A. Lymph node tuberculosis. In: Sharma SK, Mohan A (eds). Tuberculosis. 2nd edn. New Delhi: Jaypee Brothers Medical Publishers, 2009: 397–409.
  2. Ellenson LH, Perog EC. The female genital tract. In: Robbins and Cotran Pathologic Basis of disease. 9th edn. Philadelphia: Elsevier Saunders, 2014: 991−1042.
  3. Thomas SHL, White J. Poisoning. In: Colledge NR, Walker BR, Ralston SH (eds). Davidson’s principles & practice of medicine. 22nd edn. London: Churchill Livingstone, 2014: 205–230.

Internet

  1. Frontier Medical College Abbottabad, Pakistan. Available at: http://www.fmc.edu. pk/aboutus.php. Accessed October 2011.
  2. Ferro JM, Canhão P. Etiology, clinical features, and diagnosis of cerebral venous thrombosis. Available at: https://wwwuptodate.com. Accessed August 2018.

Thesis/Dissertation

  1. Khan MAH. Lipid profile and renal function status of hypothyroid patients [MD Thesis]. Dhaka: Bangabandhu Sheikh Mujib Medical University; 2005.
  2. Ahmed S. Types and abortion and its consequences - a study of 100 cases in Mymensingh Medical College Hospital [FCPS Dissertation]. Dhaka: Bangladesh College of Physicians and Surgeons; 2003.

Scientific or technical report

  1. Akutsu T. Total heart replacement device. Bethesda MD: National Institutes of Health, National Heart and Lung Institute; 1974 Apr Report No: NIH-NHLI-69-2185-4.

Accepted unpublished material

  1. Khan MAH, Majumder I, Hoque MM, Fariduddin M, Mollah FH, Arslan MI. Lipid profile in hypothyroid patients: A cross sectional study. Medicine Today. In press.

Authors

The person who mainly did the research work and wrote the paper is the first or prime author of any research paper. Other persons who made substantial contributions to the work are also listed as co-authors. It is not ethical to enlist or to be enlisted as co-authors in a research article without having substantial contribution in the research work. Those who just helped with the experiments, commented on the protocol or manuscript or helped in collection of data etc. can be acknowledged. 

Proofs

Proofs may be sent to the principal author or author for correspondence for careful correction of errors. The corrected copy must be returned to the editor-in-chief within the next 3 days. Major alteration in the text will not be accepted. 

Copyright

Accepted papers will be the permanent property of the Journal of Enam Medical College. By submitting the manuscript, the authors agree that once the article is accepted for publication, copyright of their article is automatically transferred to the Journal of Enam Medical College. 

Correspondence

All correspondence should be addressed to 

Editor-in-Chief
Journal of Enam Medical College
Enam Medical College, Savar, Dhaka
Email: thejemc2011@yahoo.com

Copyright Notice

  • Copyright on any research article is transferred in full to Journal of Enam Medical College upon publication in the journal. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
  • Articles in the Journal of Enam Medical College are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
  • This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)